Transparency is important to us, and we share our findings with the scientific community. We have presented data at numerous national and international medical meetings in order to disseminate our findings.
Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as Strategic Advisor, reinforcing its commitment to advancing early cancer detection and precision treatment.
KNOW MOREDatar Cancer Genetics (DCG) has launched Exacta AI, a next generation multi-analyte AI-driven platform providing optimised treatment options for cancer patients who have exhausted the standard options.
KNOW MOREDatar Cancer Genetics (DCG) has launched a revolutionary video-reporting service for in-vitro chemosensitivity testing, powered by AI-driven technology. This innovation provides oncologists with real-time visual evidence of chemotherapy drugs' effectiveness on a patient's tumor cells, derived from tissue biopsies or blood.
KNOW MOREThe Target-MRD blood test uses a combination of tumour-informed and tumour-agnostic molecular features for personalised, accurate and more effective monitoring of molecular residual disease.
KNOW MORECromwell Hospital, a world-leading private hospital in London, is working with Datar Cancer Genetics as a trusted second opinion partner.
KNOW MORELord Ian Botham talks not just about racism but also the value of early cancer detection as he recently took the multi-cancer detection solution Trucheck™ Intelli.
KNOW MOREDatar Cancer Genetics now has three Breakthrough Designations granted by the USFDA, including liquid biopsies for breast and prostate cancer detection.
KNOW MOREThe Trucheck™ Intelli blood test can identify 70 types of cancer, with the company hoping it can be rolled out across the NHS
KNOW MORE'Game-changer' blood test detects breast cancer earlier than X-rays, study shows.
KNOW MORELandmark Liquid Biopsy Study Shows Accurate Detection of Early-Stage Breast Cancer.
KNOW MOREDatar Cancer Genetics enters into partnership with The London Clinic to offer enhanced cancer testing services
KNOW MOREDatar's TriNetra-Prostate Blood Test Gets FDA Breakthrough Designation.
KNOW MOREGroundbreaking high-sensitivity cancer screening test arriving in SA ahead of World Cancer Day.
KNOW MOREVirtus Group announces partnership with Datar Cancer Genetics for personalised precision oncology solutions in Kuwait.
KNOW MOREUS FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics.
KNOW MOREThe Top 25 Women Leaders in Biotechnology of 2021 (Swati Deshpande - Datar Cancer Genetics)
KNOW MOREUK - National Institute for Health and Care Excellence (NICE) issues MedTech Innovation Briefing on 'Trublood-Prostate' for Precision Non-Invasive Prostate Cancer Diagnosis Described by Experts as a 'Game Changer'.
KNOW MORE